1.Evolving Paradigms in IgA Nephropathy Management: from Traditional Risk Stratification to Biomarker-Driven Precision Medicine
Dingding WANG ; Meng YAO ; Xiao LIU ; Qingxian ZHAI ; Qiong WEN ; Wei CHEN
Medical Journal of Peking Union Medical College Hospital 2026;17(2):317-323
IgA nephropathy (IgAN) is the most common primary glomerulonephritis worldwide and a major cause of chronic kidney disease and kidney failure. IgAN exhibits marked heterogeneity in clinical presentation, histopathology, and pathogenic mechanisms, contributing to variable treatment responses and prognosisamong patients. Precise risk assessment and individualized intervention are therefore of critical importance. This review systematically traces the evolution of IgAN management from traditional risk stratification toward biomarker-driven precision medicine. We first review the clinical utility and limitations of established risk stratification tools, including the KDIGO guidelines, the Oxford MEST-C classification, and the International IgAN Prediction Tool. We then discuss emerging biomarkers closely linked to disease pathogenesis, including galactose-deficient IgA1 (Gd-IgA1), anti-Gd-IgA1 autoantibodies, B cell activating factor (BAFF), a proliferation-inducing ligand (APRIL), and complement components, as well as the targeted therapies they have informed. In addition, urinary biomarkers and multi-omics approaches show promise for dynamic disease monitoring and individualized risk stratification.
2.Development of A Prognostic Prediction Model for Primary Membranous Nephropathy in the Elderly Based on Machine Learning
Yuzhu XU ; Shuqin LIU ; Dingding WANG ; Wei CHEN ; Xin WANG
Medical Journal of Peking Union Medical College Hospital 2026;17(2):370-381
Elderly patients with primary membranous nephropathy (PMN) exhibit significant prognostic heterogeneity and poor tolerance to immunotherapy. However, there is a lack of early prognostic prediction tools specifically for this population. This study aimed to develop a prognostic prediction model applicable to elderly PMN patients. This study retrospectively included elderly patients with PMN confirmed by renal biopsy. The primary endpoint was a adverse composite outcome including end-stage renal disease (ESRD), a ≥50% decline in estimated glomerular filtration rate (eGFR), or all-cause death. Patients were randomly divided into a training cohort and a validation cohort at a ratio of 7∶3. Key prognostic features were identified using least absolute shrinkage and selection operator (LASSO) regression combined with random survival forest, and a predictive model was constructed based on penalized Cox regression. Model performance was evaluated using the concordance index (C-index), time-dependent area under the receiver operating characteristic curve (AUROC), calibration curves, and decision curve analysis. The SurvSHAP (t) method was employed for interpretability analysis of the model. A total of 309 elderly patients with PMN were included in this study, with a median age of 65.00 years (IQR, 62.00-68.00) and a male predominance 61.2%(189/309).During a median follow-up of 47.00 months (IQR, 25.00-89.00), 38.2%(118/309) reached the endpoint event. The final model included nine key features, including eGFR, total protein (TP), glomerular capsular adhesion, urine glucose, segmental glomerulosclerosis proportion, fibrinogen, urea, age, and activated partial thromboplastin time (APTT). In the validation cohort, the model demonstrated good discrimination, with a C-index of 0.731(95% CI: 0.652-0.797). The time-dependent AUROCs for predicting adverse outcomes at 3, 5, and 10 years were 0.758(95% CI: 0.614-0.901), 0.781(95% CI: 0.646-0.916), and 0.866(95% CI: 0.740-0.993), respectively. Calibration curves demonstrated a high degree of concordance between predicted probabilities and actual event rates. Decision curve analysis confirmed the net clinical benefit of the model.SurvSHAP (t) analysis showed that eGFR, TP, glomerular capsular adhesion, urine glucose, and the proportion of segmental glomerular sclerosis were the top five variables contributing to the model. This prognostic model effectively predicts the risk of adverse outcomes in elderly patients with PMN in the internal validation cohort, offering a potential scientific basis for individualized risk stratification and treatment decision-making in this population.
3.Efficacy of internal limiting membrane flap technique and simple internal limiting membrane peeling in the treatment of idiopathic macular hole
Lili CHEN ; Dingding WANG ; Juanjuan WANG ; Shu ZHOU
International Eye Science 2025;25(12):2017-2021
AIM: To explore the efficacy of internal limiting membrane(ILM)flap technique and simple ILM peeling in the treatment of idiopathic macular hole(IMH)and related influencing factors.METHODS: A retrospective cohort study was conducted on totally 32 patients(35 eyes)with IMH who received surgery at our department from January 2023 to November 2024. All the patients simultaneously received phacoemulsification combined with intraocular lens implantation, and they were divided into study group(19 eyes)and control group(16 eyes), with ILM flap technique and simple ILM peeling received in the two groups, respectively. The closure situation of macular hole, best corrected vision acuity(BCVA), and macular structure were observed in the two groups of patients. Furthermore, the correlation of BCVA and healing type of macular hole at the last time of follow-up with each parameter was analyzed.RESULTS: There was no statistical difference between the two groups of patients in preoperative general characteristics(all P>0.05). At the last time of follow-up, the macular hole was heeled in both groups, with 7 eyes of U-shaped heeling, 6 eyes of V-shaped heeling, and 6 eyes of irregular heeling in the study group, and with 13 eyes of U-shaped of heeling, 1 eye of V-shaped heeling and 2 eyes of irregular heeling in the control group(χ2=7.167, P=0.028). The postoperative BCVA was better than preoperative level(all P<0.05), there were no statistical significant differences between the two groups of patients in macular choroidal thickness before and after surgery(P>0.05), but the macular retinal thickness of the study group was thinner than that of the control group(168.11±92.11 vs 235.56±92.18 μm, P=0.03). Pearson correlation analysis indicated that BCVA at the last time of follow-up was positively correlated with the preoperative minimum diameter(r=0.476, P<0.05)and the diameter hole index(r=0.361, P<0.05), and negatively correlated with traction hole index(r=-0.364, P=0.031); Keendall correlation analysis showed that the postoperative closure types positively correlated with the basal diameter(τ=0.296, P=0.029), minimum diameter(τ=0.366, P=0.007), and visual acuity at the last time of follow-up(τ=0.412, P=0.003), while negatively correlated with macular hole index(τ=-0.415, P=0.002)and traction hole index(τ=-0.511, P<0.01). During the follow-up period, neither group of patients experienced postoperative complications.CONCLUSION: Both ILM flap technique and simple ILM peeling are safe and effective in treating IMH. As the smaller the basal diameter and minimum diameter of the macular hole, the larger the macular hole index and traction hole index, the probability of U-shaped heeling after surgery is greater and the visual acuity is better.
4.Risk factors for future exacerbations in chronic obstructive pulmonary disease patients with no history of exacerbation in the past year
Dingding DENG ; Aiyun JIANG ; Shao WANG ; Xiaotao ZHANG ; Fangfang DAI ; Jun ZHU ; Ping CHEN ; Qing SONG ; Rui ZHAO
Journal of Chinese Physician 2025;27(6):821-825
Objective:To analyze the risk factors associated with future exacerbations in patients with chronic obstructive pulmonary disease (COPD) who have no history of exacerbation in the past year.Methods:COPD patients with no exacerbation history in the past year, registered in the RealDTC study from January 2018 to December 2023, were enrolled. Demographic data, COPD Assessment Test (CAT) scores, modified Medical Research Council (mMRC) dyspnea questionnaire scores, forced expiratory volume in the first second predicted of percentage (FEV 1%pred), forced expiratory volume in one second (FEV 1) to forced vital capacity (FVC), Global Initiative for Chronic Obstructive Lung Disease (GOLD) classification, GOLD groups, and inhaled medication regimens were collected. All patients were followed up for one year, and the number of exacerbations was recorded. Patients were divided into an exacerbation group and a non-exacerbation group based on the occurrence of exacerbations during the follow-up period. Logistic regression analysis was used to screen the influencing factors for exacerbations in COPD patients. Results:A total of 2 901 COPD patients were included, among which 633 patients (21.8%) experienced exacerbations during the follow-up period. Compared with the non-exacerbation group, patients in the exacerbation group were older, with higher CAT and mMRC scores, lower body mass index (BMI), FEV 1%pred, and FEV 1/FVC. The proportions of patients with high school education or above and those using long-acting β 2-agonist (LABA) + long-acting muscarinic antagonist (LAMA) medications were also lower (all P<0.05). Logistic regression analysis showed that age ( OR=1.010, 95% CI: 1.000-1.021), CAT score ≥20 ( OR=1.415, 95% CI: 1.074-1.865), education level of junior high school or below ( OR=1.243, 95% CI: 1.003-1.540), LABA + LAMA inhalation ( OR=0.605, 95% CI: 0.432-0.848), and BMI ( OR=0.969, 95% CI: 0.943-0.995) were independent risk factors for future exacerbations in COPD patients with no exacerbation history in the past year (all P<0.05). Conclusions:The risk of future exacerbations remains high in COPD patients with no exacerbation history in the past year. High CAT scores, low education levels, and low BMI are associated with future exacerbations. Clinicians should pay close attention to the management of such patients and implement appropriate interventions.
5.Participation of lysine lactylation in neuropsychiatric system disorders
Qiang ZHU ; Weishi CHEN ; Dingding LIU ; Guirong ZENG
Chinese Journal of Pathophysiology 2025;41(10):2053-2058
Lysine lactylation is a type of histone post-translational modification that is mainly regulated by fac-tors such as lactate level,glycolysis level,and vario us enzymes and proteins.Lysine lactylation involves several physio-pathological activities,including macrophage inflammatory response,somatic cell reprogramming,neuronal activity,and embryonic development,etc.Changes in the level of lactfication modification are involved in the development of neuropsy-chiatric disorders such as Alzheimer disease(AD),schizophrenia(SCZ)and depression.Inflammatory response and ab-normal neuronal activity are one of the important causes of neuropsychiatric diseases.The change of lactfication modifica-tion level participates in the development of AD,SCZ,depression and other neuropsychiatric diseases,which specifically regulate neuronal apoptosis,neuronal excitation,and microglial inflammatory response.
6.Participation of lysine lactylation in neuropsychiatric system disorders
Qiang ZHU ; Weishi CHEN ; Dingding LIU ; Guirong ZENG
Chinese Journal of Pathophysiology 2025;41(10):2053-2058
Lysine lactylation is a type of histone post-translational modification that is mainly regulated by fac-tors such as lactate level,glycolysis level,and vario us enzymes and proteins.Lysine lactylation involves several physio-pathological activities,including macrophage inflammatory response,somatic cell reprogramming,neuronal activity,and embryonic development,etc.Changes in the level of lactfication modification are involved in the development of neuropsy-chiatric disorders such as Alzheimer disease(AD),schizophrenia(SCZ)and depression.Inflammatory response and ab-normal neuronal activity are one of the important causes of neuropsychiatric diseases.The change of lactfication modifica-tion level participates in the development of AD,SCZ,depression and other neuropsychiatric diseases,which specifically regulate neuronal apoptosis,neuronal excitation,and microglial inflammatory response.
7.Digital-Intellectualized Upgrade and Clinical Application of National Rare Diseases Registry System of China
Jian GUO ; Ye JIN ; Peng LIU ; Dingding ZHANG ; Limeng CHEN ; Yicheng ZHU ; Shuyang ZHANG
JOURNAL OF RARE DISEASES 2025;4(1):54-60
Since its establishment in 2016, the National Rare Diseases Registry System of China (NRDRS) has accumulated valuable case data and bio-specimen for basic and clinical research on rare diseases in China. However, the emerging challenges in clinical diagnosis and treatment of rare diseases make it unable for data and resource platform to fully meet the diversified needs. Under this backdrop, we have developed a protocol to optimize and upgrade the system based on the core functions of the NRDRS platform. The goal is to leverage intelligent digital technologies to transform NRDRS into a new platform integrating multimodal data and auxiliary diagnostic and treatment functions. It is specified as the development and construction of "one platform and four intelligent tools." Currently, we have upgraded and developed NRDRS platform, intelligent tool for genotype-phenotype analysis of rare diseases, AI-assisted diagnostic tool for rare diseases, remote multidisciplinary diagnosis and teaching tool for rare diseases, drug screening and validation tool for rare diseases. The next step will focus on the promotion of the application of these tools in clinical settings in order to address the issue of severe imbalance in the allocation of resources for the diagnosis and treatment of rare diseases. This article provides an overview of the digital and intelligent upgrades of the NRDRS, the trials in applications in clinical settings, and direction in the future.
8.Research hotspots,frontier changes,and trend prospects of neuromuscular training
Hao TIAN ; Dingding CHEN ; Deng WANG ; Qiang YE
Chinese Journal of Tissue Engineering Research 2025;29(24):5148-5157
BACKGROUND:With the rise of sports medicine,neuromuscular training has become a popular area of research in recent years,and a large number of results have been achieved.However,existing research lacks a comprehensive and systematic review,underscoring the need for a holistic and systematic synthesis to elucidate the current status,key issues,and trends in this field.OBJECTIVE:To conduct a comprehensive overview of the current status,characteristics,and trends of research in the field of neuromuscular training.METHODS:A search of the Web of Science Core Collection database was conducted for peer-reviewed English-language journal articles regarding neuromuscular training.Conference papers,reviews,book chapters,and irrelevant papers were excluded,and a total of 3 102 core literature items were included.The bibliometric and visualization analyses of the included literature were conducted using the VOSviewer 1.6.20 and Citespace software.RESULTS AND CONCLUSION:(1)Research in the field of neuromuscular training has entered a phase of sustained growth in the last decade.(2)The University of Cincinnati is the most influential institution in this field,having fostered a closely cooperating research team,including Prof.Gregory D.Myer,who has made significant contributions to the development of the field.The American Journal of Sports Medicine is the most prominent journal in this field,and because of its multifaceted strengths,the United States dominates research in this area.(3)The research topics that have attracted the greatest attention include neuromuscular control(centrality:0.09),injury(centrality:0.02),and kinesiology(centrality:0.06).The research in this field is characterized by a systematic,prospective,effective and applied approach.The mechanisms of injury rehabilitation and functional reconstruction,characteristics of sports performance and intervention strategies,rehabilitation training methods and countermeasures,and risk prevention interventions and validation of the effects are the focus of the researchers'continuous attention.(4)The principal burst words include anterior cruciate ligament(emergent intensity:33.23)and activation(emergent intensity:22.7).The evolution of research frontiers indicates a shift in perspective from localization to systematic integration.The research objective has transitioned from a primary focus on prevention and treatment to a more holistic approach that encompasses capacity enhancement.Additionally,the emphasis has shifted from merely activating the process to achieving precise control.(5)It is recommended that future research should further promote cross-disciplinary collaboration and facilitate the development of neuromuscular training towards diversification,individualization and long-term effectiveness.
9.5 Hz microcurrent stimulation before bedtime improves sleep and mental state
Weiyi ZHOU ; Wei LUO ; Lele CHEN ; Dingding WANG ; Renlai ZHOU
Space Medicine & Medical Engineering 2025;36(3):199-205
Objective Previous studies have suggested that bilateral 5-Hz microcurrent stimulation has a hypnotic effect,but the lack of evidence on how the stimulation affects subjects'sleep limits the validation of this intervention.To address this gap,a crossover experimental design was employed,recruiting both insomnia and non-insomnia subjects.Methods 10 participants with insomnia and 10 healthy participants were selected to attend our study.In this crossover study,true(5 Hz)vs.sham stimulation was applied over the parietal temporal lobes.Impact of stimulation on subjective sleep experience,sleep efficiency,sleep structure and psychomotor vigilance task(PVT)was assessed.Results Subjects who received the true 5-Hz stimulation before bedtime had significantly enhanced sleep efficiency,sleep quality,and mental state compared to the night of sham stimulation.Additionally,subjects who received true stimulation exhibited higher sleep efficiency and a later appearance of dream sleep.These findings suggest that 5-Hz microcurrent stimulation before bedtime can enhance both objective and subjective sleep efficiency.Conclusion 5 Hz microcurrent stimulation before bedtime improved sleep efficiency of subjects and also enhanced their subjective perception of sleep.
10.Risk factors for future exacerbations in chronic obstructive pulmonary disease patients with no history of exacerbation in the past year
Dingding DENG ; Aiyun JIANG ; Shao WANG ; Xiaotao ZHANG ; Fangfang DAI ; Jun ZHU ; Ping CHEN ; Qing SONG ; Rui ZHAO
Journal of Chinese Physician 2025;27(6):821-825
Objective:To analyze the risk factors associated with future exacerbations in patients with chronic obstructive pulmonary disease (COPD) who have no history of exacerbation in the past year.Methods:COPD patients with no exacerbation history in the past year, registered in the RealDTC study from January 2018 to December 2023, were enrolled. Demographic data, COPD Assessment Test (CAT) scores, modified Medical Research Council (mMRC) dyspnea questionnaire scores, forced expiratory volume in the first second predicted of percentage (FEV 1%pred), forced expiratory volume in one second (FEV 1) to forced vital capacity (FVC), Global Initiative for Chronic Obstructive Lung Disease (GOLD) classification, GOLD groups, and inhaled medication regimens were collected. All patients were followed up for one year, and the number of exacerbations was recorded. Patients were divided into an exacerbation group and a non-exacerbation group based on the occurrence of exacerbations during the follow-up period. Logistic regression analysis was used to screen the influencing factors for exacerbations in COPD patients. Results:A total of 2 901 COPD patients were included, among which 633 patients (21.8%) experienced exacerbations during the follow-up period. Compared with the non-exacerbation group, patients in the exacerbation group were older, with higher CAT and mMRC scores, lower body mass index (BMI), FEV 1%pred, and FEV 1/FVC. The proportions of patients with high school education or above and those using long-acting β 2-agonist (LABA) + long-acting muscarinic antagonist (LAMA) medications were also lower (all P<0.05). Logistic regression analysis showed that age ( OR=1.010, 95% CI: 1.000-1.021), CAT score ≥20 ( OR=1.415, 95% CI: 1.074-1.865), education level of junior high school or below ( OR=1.243, 95% CI: 1.003-1.540), LABA + LAMA inhalation ( OR=0.605, 95% CI: 0.432-0.848), and BMI ( OR=0.969, 95% CI: 0.943-0.995) were independent risk factors for future exacerbations in COPD patients with no exacerbation history in the past year (all P<0.05). Conclusions:The risk of future exacerbations remains high in COPD patients with no exacerbation history in the past year. High CAT scores, low education levels, and low BMI are associated with future exacerbations. Clinicians should pay close attention to the management of such patients and implement appropriate interventions.

Result Analysis
Print
Save
E-mail